Immunolocalization of lipid peroxidation/advanced glycation end products in amyloid A amyloidosis

Free Radical Biology and Medicine

Volumn 36, Issue 5, 2004, Pages 657-664

  Kamalvand, Golnar ^a   Ali Khan, Z ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

4 Hydroxy 2 nonenal; AA amyloid; Advanced glycation end product; Alveolar hydatid cyst; Immunohistochemistry; Lipid peroxidation; N (carboxymethyl)lysine; Oxidative stress; Red pulp; Reticuloendothelial cells; Splenic perifollicular zone

Indexed keywords

4 HYDROXYNONENAL; 6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; AMYLOID A PROTEIN; CELL MARKER;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RETICULOENDOTHELIAL SYSTEM; SPLEEN; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 1242270687     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.12.011     Document Type: Article

References (44)

1. G.G. Glenner, Amyloid deposits and amyloidosis: the beta-fibrillogenesis. N. Engl. J. Med. 302:1283-1292, 1333-1343; 1980.
2. Benson M.D. Amyloidosis. Scriver C.R., Beaudet A.L., Sly W.S., Valle D.V. The metabolic basis of inherited disease. 1995;4159-4191 McGraw-Hill, New York.
3. Ali-Khan Z., Li W., Chan S.L. Animal model for the pathogenesis of reactive amyloidosis. Parasitol. Today. 12:1996;297-302.
4. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;1989-1993.
5. Yan S.D., Zhu H., Zhu A., Golabek A., Du H., Roher A., Yu J., Soto C., Schmidt A.M., Stern D., Kindy M.S. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature. 6:2000;643-651.
6. Ali-Khan Z., Jothy S., Alkarmi T.O. Murine alveolar hydatidosis: a potential experimental model for the study of AA amyloidosis. Br. J. Exp. Pathol. 64:1983;599-611.
7. Maury C.P.J., Titinen S., Laiho K., Kaarela K., Liljestrom M. Raised circulating interleukin-18 levels in reactive AA amyloidosis. Amyloid: J. Protein Folding Disord. 9:2002;141-144.
8. Ando Y., Nyhlin N., Suhr O., Holmgren G., Uchida K., El Sahly M., Yamashita T., Terasaki H., Nakamura M., Uchino M., Ando M. Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem. Biophys. Res. Commun. 232:1997;497-502.
9. Kamalvand G., Pinard G., Ali-Khan Z. Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis. Amyloid: Int. J. Exp. Clin. Invest. 10:2003;151-159.
10. Chan S.L., Chronopoulos S., Murray J., Laird D.W., Ali-Khan Z. Selective localization of murine ApoSAA1/SAA2 in endosomes-lysosomes of activated macrophages and their degradation products. Amyloid: Int. J. Exp. Clin. Invest. 4:1997;40-48.
11. Bell A.W., Chan S.L., Ali-Khan Z. N-terminal sequence analysis of SAA-derivatives purified from murine inflammatory macrophages. Amyloid: Int. J. Exp. Clin. Invest. 6:1999;31-36.
12. Kluve-Beckerman B., Liepnieks J.J., Wang L., Benson M.D. A cell culture system for the study of amyloid pathogenesis: amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am. J. Pathol. 155:1999;123-133.
13. Kluve-Beckerman B., Manaloor J.J., Liepnieks J.J. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum. 46:2002;1905-1913.
14. Ali-Khan Z. Searching for an in vivo site for nascent amyloid fibril formation. J. Alzheimers Dis. 81:2002;105-114.
15. Sayre L.M., Smith M.A., Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:2001;721-738.
16. Esterbauer H., Schaur R.G., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
17. Miyata T., Wada Y., Cai Z., Iida Y., Horie K., Yasuda Y., Maeda K., Kurokawa K., van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 51:1997;1170-1181.
18. Ando Y., Brannstrom T., Uchida K., Nyhlin N., Nasman B., Suhr O., Yamashita T., Olsson T., El Salhy M., Uchino M., Ando M. Histochemical detection of 4-hydroxynonenal protein in Alzheimer's amyloid. J. Neurol. Sci. 156:1998;172-176.
19. Takeda A., Smith M.A., Avila J., Nunomura A., Siedlak S.L., Zhu X., Perry G., Sayre L.M. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2-nonenal. J. Neurochem. 75:2000;1234-1241.
20. Röcken C., Kientsch-Engel R., Mansfeld S., Stix B., Stubenrauch K., Weigle B., Buling F., Schwan M., Saeger W. Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis. Am. J. Pathol. 162:2003;1213-1220.
21. Uesugi N., Sakata N., Nagai R., Jono T., Horiuchi S., Takebayashi S. Glycoxidative modification of AA amyloid deposits in renal tissue. Nephrol. Dial. Transplant. 15:2000;355-365.
22. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stern D., Sayre L.M., Monnier V.N., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
23. ε- (carboxymethyl)lysine and hexitol-lysine. Free Radic. Biol. Med. 31:2001;175-180.
24. Miyata T., van Ypersele de Strihou C., Kurokawa K., Baynes J.W. Alterations in non-enzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int. 55:1999;389-399.
25. Miyata T., Ueda Y., Saito A., Kurokawa K. 'Carbonyl stress' and dialysis-related amyloid. Nephrol. Dial. Transplant. 15(Suppl. 1):2000;25-28.
26. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe M., Inagaki T., Washimi Y., Yasuda Y., Horie K., Miyata T., Sobue G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol. 104:2002;113-122.
27. Grune T., Merker K., Sandig G., Davies K.J. Selective degradation of oxidatively modified protein substrates by the proteasome. Biochem. Biophys. Res. Commun. 305:2003;709-718.
28. Grune T., Davies K.J. The proteosomal system and HNE-modified proteins. Mol. Aspects Med. 24:2003;195-204.
29. Chronopoulos S., Lembo P., Alizadeh-Khiavi K., Ali-Khan Z. Ubiquitin: its potential significance in murine AA amyloidogenesis. J. Pathol. 167:1992;249-259.
30. Ali-Khan Z. Cellular changes in the lymphoreticular tissue of C57L/J mice infected with Echinococcus multilocularis cysts. Immunology. 34:1978;831-839.
31. Chronopoulos S., Laird D.W., Ali-Khan Z. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J. Pathol. 173:1994;361-369.
32. 2. Biochem. J. 332:1997;663-669.
33. Ali-Khan Z., Rausch R.L. Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann. Trop. Med. Parasitol. 81:1987;381-392.
34. Du T., Ali-Khan Z. Pathogenesis of secondary amyloidosis in an alveolar hydatid cyst-mouse model: histopathology and immuno/enzyme-histochemical analysis of splenic marginal zones during amyloidogenesis. J. Exp. Pathol. 71:1990;313-335.
35. Phipps-Yonas H., Pinard G., Ali-Khan Z. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis. Scan. J. Immunol. 2004;. (in press).
36. Yamamoto T., Shibata N., Muramatsu F., Sakayori N., Kobayashi M. Oxidative stress in the human fetal brain: an immunohistochemical study. Pediatr. Neurol. 26:2002;116-122.
37. Devouge M., Ali-Khan Z. Intraperitoneal murine alveolar hydatidosis: relationship between the size of the larval cyst mass, immigrant inflammatory cells, splenomegaly and thymus involution. Tropenmed. Parasit. 34:1983;15-20.
38. Treves S., Ali-Khan Z. Characterization of the inflammatory cells in progressing tumor-like alveolar hydatid cysts1. Kinetics and composition of inflammatory infiltrates. Tropenmed. Parasit. 35:1984;183-188.
39. Ali-Khan Z., Sipe J.D., Du T., Riml H. Echinococcus multilocularis: relationship between persistent inflammation, serum amyloid A protein response and amyloidosis in four mouse strains. Exp. Parasitol. 67:1988;334-345.
40. ε-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271:1996;9982-9986.
41. Okada K., Wangpoengrakul C., Osawa T., Toyokunit S., Tanaka K., Uchida K. 4-Hydroxy-2-nonenal impairment of intracellular proteolysis during oxidative stress. J. Biol. Chem. 274:1999;23787-23793.
42. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
43. Vitek M.P., Bhattacharya K., Glendening M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;4766-4770.
44. Crabb J.W., O'Neil J., Miyagi M., West K., Hoff H.F. Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues. Protein Sci. 11:2002;831-840.